Faculty

Natalie Alizaga, PhD

Postdoc Scholar
Cardiovascular Research Inst

Natalie M. Alizaga, PhD received her doctorate in Applied Social Psychology from The George Washington University in Washington DC, a MPH in Health Behavior and Health Education from The University of Michigan, Ann Arbor, and a BS in Health Science from San Jose State University.  Her research interests focus on elucidating the psychosocial factors related to tobacco cessation and cancer prevention for underserved populations, including barriers and facilitators to routine health care and screening.

Stacey Anderson, PhD

Assistant Adjunct Professor
Social Behavioral Sciences

Dr. Anderson's  research interests lie at the intersection of public health policy and social cognition.  She investigates marketing strategies that tap implicit constructs of self and perceptions of others, pair brand identities with personal identities, and encourage consumption of products detrimental to individual and public health. 

Department: Social and Behavioral Sciences
 

Professional Activities: 
Reviewer for the following:

Mehrdad Arjomandi, MD

Assistant Professor In-Residence of Medicine
Medicine

Dr. Arjomandi is Associate Professor of Medicine in the Division of Pulmonary, Critical Care, Allergy, Immunology, and Sleep Medicine at UCSF with a joint appointment at San Francisco Veterans Affairs Medical Center. He is Associate Director of the UCSF Human Exposure Laboratory at San Francisco General Hospital, and an investigator at the UCSF Center for Tobacco Control Research and Education.

John Balmes, MD

Prrofessor in Residence
Medicine

Dr. Balmes received his MD degree from Mount Sinai School of Medicine in 1976. After internal medicine training at Mount Sinai and pulmonary subspecialty, occupational medicine, and research training at Yale, he joined the faculty of USC in 1982. He joined the faculty at UCSF in 1986 and is currently Professor and Division Chief of Occupational and Environmental Medicine at San Francisco General Hospital (SFGH).

Neal Benowitz, MD

Professor In Residence
Medicine

Neal Benowitz has been conducting research at SFGH since 1973. His research focus is on the human pharmacology of nicotine in relation to pathogenesis of and individual differences in vulnerability to tobacco-related disease, and the use of pharmacologic data as a basis for public health policies to prevent and reduce such disease. He has served on a number of national and international committees addressing issues in tobacco-related diseases and smoking cessation, including several sponsored by the Institute of Medicine.

Dharma Bhatta, PhD

Postdoc Scholar
Cardiovascular Research Inst

Dharma Bhatta, PhD received his doctorate in Epidemiology from the Prince of Songkla University, Thailand in 2016. He is an epidemiologist and public health expert/researcher, with over ten years of experiences in academia and public health research in developing countries. Dr.

Stella Bialous, RN, DrPH

Assoc Professor in Residence
Social Behavioral Sciences

Dr. Stella Bialous’ research focuses on the WHO Framework Convention on Tobacco Control, tobacco industry monitoring and building nurses’ capacity for tobacco control nationally and internationally. Dr. Bialous has consulted with the World Health Organization’s Tobacco Free Initiative for over 15 years.  In 2003, she received the American Legacy Foundation’s Sybill G.

Paul Blanc, MD

Division Chief
Medicine

Dr. Paul D. Blanc MD MSPH is Professor of Medicine and holds the Endowed Chair in Occupational and Environmental Medicine at the University of California San Francisco, where he has been on faculty since 1988. He received his BA from Goddard College (Plainfield, Vermont), where he first became interested in health and the environment, later training at the Harvard School of Public Health (in industrial hygiene), the Albert Einstein School of Medicine, and Cook County Hospital (in a joint Occupational Medicine and Internal Medicine Residency).

Candice Bowling, JD, MPA

Postdoctoral Scholar
Institute for Health Policy Studies

Candice M.

Mai-Khanh Bui-Duy, MD

Assistant Clinical Professor
Medicine

Mai-Khanh Bui-Duy, MD is Assistant Clinical Professor in the Division of General Internal Medicine at UCSF and currently practices at both the General Medicine Clinic at 1701 Divisadero Street as well as at the Screening and Acute Care Clinic. She completed her internal medicine residency at UCSF in the UC Primary Care program, participating in the Health Systems and Leadership Area of Distinction. 

Esteban G. Burchard, MD, MPH

Professor
Bioengineering

The overall goal of my research group is to identify and characterize genetic, environmental and social factors that predispose to asthma and modify drug response (pharmacogenetics). In addition, we are interested in how racially-specific genetic diffs. modify disease and response to treatment. My major scientific interests center on identifying genetic risk factors for common diseases and traits (e.g. asthma and drug response) in racial/ethnically mixed populations. I am fascinated with how racial/ethnic background influences health and risk of disease.

Carolyn Calfee, MD, MAS

Assistant Professor of Medicine
Medicine

Research focuses on the effects of active and passive smoking on susceptibility to acute lung injury, a major cause of respiratory failure in critically ill patients. In addition, she is interested in the use of biomarkers to measure cigarette smoke exposure.

Timothy Carmody, PhD

Clinical Professor
Psychiatry

Dr. Carmody's work focuses on the treatment of nicotine dependence in adult chronic smokers. Dr. Carmody has several professional interests in the field of behavioral medicine, including treatment of nicotine dependence, chronic pain, behavioral factors in coronary heart disease, and obesity/weight management.  His primary interest is in the treatment of nicotine dependence in adult chronic smokers. 

Janine Cataldo, RN, PhD, FAAN

Associate Professor and Chair
Physiological Nursing

Dr. Cataldo's research and clinical foci include: older adults’ risk perceptions of conventional, new and emerging  tobacco  products, and e- cigarettes, how these perceptions are affected by pro- and anti-tobacco messages; the impact of tobacco industry activities on older smokers and geriatric science; lung cancer stigma, symptom burden, and quality of life; and use of virtual worlds as an mHealth intervention to decrease lung cancer stigma and improve patient-clinician communication. Dr.

Benjamin Chaffee, DDS, MPH, PhD

Assistant Professor
Preventive & Restor Dent Sci

The overarching goal of our team’s epidemiologic research program is to understand how various behaviors, biological attributes, and social circumstances influence health and disease distributions, often inequitably, across populations. Application of such knowledge aims to inform future public health practices, health policies, and clinical guidelines that elevate the health of patients and vulnerable communities, both locally and worldwide.

Jing Cheng, MD, MS, PhD

Adjunct Professor
Preventive & Restor Dent Sci

Dr. Cheng earned her medical degree in China, M.S. in nutrition at Cornell University in 2002, and Ph.D. in biostatistics at the University of Pennsylvania in 2006. Before joining UCSF School of Dentistry in 2010, Dr. Cheng was an Assistant Professor in Biostatistics at the University of Florida’s College of Medicine.

Robin Corelli, PharmD

Professor
Clinical Pharmacy

Primary interest in tobacco cessation education and training. Dr. Corelli has co-coordinated, with other Tobacco Center members (Drs. Hudmon and Kroon), a comprehensive tobacco cessation training program, Rx for Change: Clinician-Assisted Tobacco Cessation, for students in the health professions.

Eric Crosbie, PhD

Postdoctoral Scholar
Cardiovascular Research Inst

Eric Crosbie recently received his PhD in Politics at the University of California, Santa Cruz (UCSC).

Kevin Delucchi, PhD

Professor in Residence
Psychiatry

Dr. Delucchi is a quantitative expert specializing in psycho-social research. Dr. Delucchi's work focuses on statistical methods for analysis of quantitative data including clinical trials of treatments for smoking cessation. He has collaborated with numerous investigators on nicotine-related research and is a member of an NIH Study Section.

Stuart Gansky, MS, DrPH

Professor, School of Dentistry
Preventive & Restor Dent Sci

My research concentrates on oral health research, health disparities research, applied statistical analyses and related method­ological issues. Balancing these components is essential to successful and practical oral epidemiology research. Methodological examination helps ground health research and build convincing argu­ments, while collaborative health research generates opportunities for innovative statistical practice and provides challenges for developing ways to solve real world problems

Peter Ganz

Chief, Cardiology/SFGH
Medicine

Dr. Ganz is the Chief of Cardiology and the Director of the Center of Excellence in Vascular Research at the San Francisco General Hospital. He is the Maurice Eliaser Distinguished Professor of Medicine at the University of California, San Francisco. Dr. Ganz has been a pioneer and a leader in translational vascular research. He has focused on understanding key elements of human atherosclerosis including the pathobiology of the human endothelium, the biology of vascular nitric oxide, systemic and vascular inflammatory responses and atherosclerotic plaque instability.

Stanton Glantz, PhD

Professor of Medicine
Medicine

RESEARCH INTERESTS: Dr. Glantz, the Truth Initiative Distinguished Professor of Tobacco Control, conducts research on a wide range of topics ranging from the health effects of secondhand smoke (with particular emphasis on the cardiovascular system) to the efficacy of different tobacco control policies. As the tobacco landscape has changed, Dr. Glantz' work has expanded to include e-cigarettes and marijuana, both of which are expanding the tobacco epidemic.

Warren Gold, MD

Professor of Medicine
Medicine

Major academic activities include clinical research programs, training in systems physiology, supervision of the Adult Pulmonary Laboratories, consulting with industry on systems physiology, including the effects of secondhand smoke on lung function. After internal medicine and chief medical residency at the Beth Israel Hospital in Boston (1959-62), he received his research training at the Cardiovascular Research Institute, UCSF with Jay A. Nadel and Julius H.

Jeffrey Gotts, MD, PhD

Assistant Professor
Medicine

Research focuses on the effects of cigarette smoke and e-cigarette aerosols on susceptibility to acute respiratory distress syndrome (ARDS), a major cause of respiratory failure in critically ill patients.

Jennifer Grandis, MD

Professor, Otolaryngology – Head and Neck Surgery
Associate Vice Chancellor, Clinical and Translational Science Institute
Otolaryngology

Jennifer R. Grandis, MD, is a Professor in the Department of Otolaryngology – Head and Neck Surgery (OHNS), and she is the Associate Vice Chancellor—Clinical and Translational Research (AVC-CTR) at the University of California, San Francisco. She received her medical degree from the University of Pittsburgh School of Medicine, Pennsylvania, and she completed her internship from the same institution. Dr. Grandis completed both a residency and an Infectious Disease fellowship from the University of Pittsburgh School of Medicine, Pennsylvania. Prior to joining UCSF, Dr.

Lawrence Green, DrPH, MPH

Professor Emeritus
Epidemiology & Biostatistics

Research on health promotion, including tobacco control, with particular emphasis on knowledge dissemination, transfer, program planning and implementation strategies. His interest is in making practice more evidence-based by making evidence more practice-based. Dr. Green has been the PI on research grants and on predoctoral and postdoctoral training grants from NIH,, the VA , CDC, AHRQ, and the Canadian Institute for Health Research.

Noah Gubner, PhD

Postdoctoral Scholar
Institute for Health Policy Studies

Noah received his PhD in Behavioral Neuroscience at Oregon Health & Science University in Portland, OR. His dissertation research utilized behavioral and genetic animal models that have been well established for alcohol research to study the combined effects of nicotine and alcohol on reward and neuroadaptation, with the goal of understanding why these two drugs share such a high rate of co-abuse.

Joe Guydish, PhD

Professor in Residence
Institute for Health Policy Studies

Research on access, delivery, and organization of substance abuse treatment services, treatment effectiveness, and adoption of new treatments into practice settings. He is currently testing an organizational change intervention for treatment programs in tobacco dependence. Joseph Guydish, PhD, MPH, is Professor of Medicine and Health Policy at the University of California, San Francisco.   His research concerns access, delivery, and organization of substance abuse treatment services.

Sharon Hall, PhD

Professor Emeritus
Psychiatry

Major areas of research are clinical trials for the treatment of nicotine dependence, with emphasis on treatments that reflect a chronic disease model, and on complex populations.

Yogi Hendlin, PhD

Postdoctoral Scholar
Cardiovascular Research Inst

Yogi Hale Hendlin earned his PhD in Environmental Philosophy at the University of Kiel, Germany, after completing doctoral work at UCLA, a Master's at the London School of Economics, and degrees at UC Berkeley. Hendlin's interests are at the intersection of public health policy, social and environmental justice, business ethics, and the philosophy of science.

Robert A. Hiatt, MD, PhD

Professor
Epidemiology & Biostatistics

Primarily focused on cancer epidemiology and studies of cancer etiology, early development, the environment and social determinants.  Dr.

Minji Kim, PhD

Postdoctoral Scholar
Cardiovascular Research Inst

Minji Kim's research interest focuses on message effects and persuasion. She is particularly interested in the effect and boundary conditions of tailored communication. Kim received a Ph.D. in Communication from the Annenberg School for Communication, University of Pennsylvania, with a dissertation examining the positive and negative role of character-audience similarity in anti-smoking campaigns using various themes.

Lisa Kroon, PharmD

Professor & Chair
Clinical Pharmacy

Dr. Lisa Kroon is a Professor and Chair of the Department of Clinical Pharmacy in the School of Pharmacy at the University of California in San Francisco. Dr. Kroon received her Doctor of Pharmacy at the University of Michigan and then completed two years of residency at UCSF in pharmacy practice and hospital pharmacy administration. She has been a member of the UCSF faculty since 1996. She practices in the UCSF Medical Center’s Adult Diabetes Clinic and Diabetes Teaching Center, where she cares for people with diabetes and chronic illnesses.

Susan Lee, MD

TICR Graduate Programs
Anesthesia

Dr. Susan M.Lee recently completed a trial investigating a smoking cessation program implemented preoperatively, through which she gained an understanding of the challenges of implementing a multidisciplinary program and techniques to overcome these challenges.  She has since successfully established strong ties with community agencies, such as the Smokers' Helpline, and collaborated with other researchers, culminating in a peer-reviewed publication and implementation of the program clinically.

James Lightwood, PhD

Associate Professor
Clinical Pharmacy

Research program involves estimating the changes in direct healthcare costs due to changes in smoking behavior in large populations, and changes in exposure to passive smoking and health care cost and utilization attributable to adoption of smoke-free laws. Dr. Lightwood has done research in cost-benefit and cost-effectiveness analysis of disease prevention and management programs, cost savings attributable to smoking cessation, and the economics of infectious disease control

Pamela Ling, MD

Professor
Medicine

Dr. Ling studies tobacco industry marketing strategies targeting young adults, women, and other high risk population, and new smokeless and novel tobacco product marketing strategies.  She also studies how to use tobacco industry marketing strategies to improve tobacco control programs.

Ruth Malone, RN, PhD, FAAN

Professor
Social Behavioral Sciences

Research focuses on tobacco industry activities aimed at undermining public health, strategic positioning and messaging, marginalized populations, and emerging developments in the social construction of tobacco use. Dr. Malone is known nationally and internationally for her research on the tobacco industry’s strategic efforts to counter public health. Her work is funded by the National Cancer Institute, NIH, and by the California Tobacco-Related Disease Research Program. She has served as a consultant on tobacco industry activities for the U.S.

Jyothi Marbin, MD

Associate Clinical Professor
Pediatrics

Jyothi Marbin, MD, is an Associate Clinical Professor in the Department of Pediatrics at UCSF. She is the director of the Pediatrics Leadership for the Underserved Residency program, and is an Associate Program Director of the Pediatrics Residency Program at UCSF.

As an educator, Dr. Marbin is interested in developing curricula around building leadership skills to further social justice and health equity. Her areas of interest include diversity and inclusion, design thinking and adaptive leadership skills, including reflection and mindfulness.

Gregory Marcus

Associate Professor, Department of Medicine
Medicine

CLINICAL
Dr. Gregory Marcus is a specialist in the treatment of arrhythmias, including mapping and catheter ablation for atrial fibrillation, supraventricular tachycardias and ventricular arrhythmias. He is also an expert in pacemaker, biventricular device and defibrillator implantation.

Michael Matthay, MD

Director of the Critical Care Medicine Training
Associate Director of the Intensive Care Unit
Professor
Medicine

Michael A. Matthay, MD is a Professor of Medicine and Anesthesia at the University of California at San Francisco and a Senior Associate at the Cardiovascular Research Institute. He is Director of the Critical Care Medicine Training in the Department of Medicine and Associate Director of the Intensive Care Unit. He received his AB from Harvard University in 1969 and his MD from the University of Pennsylvania School of Medicine in 1973. Dr.

Wendy Max, PhD

Director & Prof. of Economics
Institute for Health Aging

Wendy Max, Ph.D. is Professor of Health Economics and Co-Director of the Institute for Health & Aging at the University of California, San Francisco. She has been on the faculty at UCSF since 1987. Dr. Max holds a PhD in economics from the University of Colorado, Boulder. Her recent research has focused on modeling the economic impact of tobacco on healthcare expenditures. She has estimated national costs of smoking; costs to Medicare, Medicaid, and private payers; costs in California; and the impact on communities of color.

Julia Mcquoid, PhD

Postdoc Scholar
Cardiovascular Research Inst

I am a health geographer interested in qualitative and mixed methods approaches to understanding relationships between people’s everyday environments and behaviors related to health and wellbeing. During my fellowship at the Center for Tobacco Control Research and Education at UCSF, I am researching place-embedded social practices of smoking within marginalized groups, such as young LGBTQI adults, in order to better understand the persistence of smoking within these groups and inform the design and effectiveness of tobacco control efforts.

Dieter Meyerhoff, PhD

Professor in Residence
Radiology

Dieter Meyerhoff, PhD, is a Professor in Residence in the Department of Radiology at the University of California, San Francisco and at the San Francisco Veterans Affairs Medical Center. He is also Co-Director of the Treatment Research Center in the Department of Psychiatry at UCSF. Dr. Meyerhoff completed his undergraduate degree in Chemistry from Westphälische Wilhelms Universität in Münster, Germany, and he obtained his PhD in Chemistry at Westphälische Wilhelms Universität, followed by a postdoctoral fellowship from the University of California, Berkeley Department of Chemistry.

Ricardo Munoz, PhD

SENATE EMERITUS (WOS)

Tung Nguyen, MD

Professor
Medicine

I am the Stephen J. McPhee, MD Endowed Chair in General Internal Medicine and Professor of Medicine at the University of California, San Francisco (UCSF). I am a practicing general internist with a large panel of Asian American patients and teach students and medical residents about medicine, health disparities, and community-based participatory research (CBPR).

Nhung Nguyen, PhD

Postdoctoral Scholar
Cardiovascular Research Inst

Nhung Nguyen received her PhD in Epidemiology from The University of Texas Health Science Center at Houston, TX, and her BS in Pharmacy from Hanoi University of Pharmacy, Vietnam. Her dissertation was among the first to examine smoking prevalence, nicotine dependence, and related factors among HIV-positive people in Vietnam. Her research interests include application of technology and data science in smoking cessation intervention among smokers with polysubstance use, and in smoking prevention among youth and young adults. 

Daniel Orenstein, JD, MPH

Postdoctoral Scholar
Institute for Health Policy Studies

Daniel G. Orenstein, JD, MPH, received a law degree from Arizona State University (2011), an MPH in Health Policy from Harvard (2016), and a BA in Political Science and Sociology from the University of Arizona (2005).  Following law school, Dan served as Deputy Director of the Network for Public Health Law in the Western Region, providing technical assistance on a wide variety of public health legal issues.

Danielle Ramo, PhD

Asst Professor In Residence
Psychiatry

Dr. Danielle Ramo is Assistant Professor and licensed psychologist in the Department of Psychiatry and the Helen Diller Family Comprehensive Cancer Center at UCSF. She directs the Research on Addictions and Digital Interventions lab (readi.ucsf.edu). Her research program focuses on using digital media to change risky drug and alcohol use. Dr. Ramo has developed the Facebook Tobacco Status Project social media intervention to help young adults quit smoking, and is leading three clinical trials testing the efficacy of social media-mediated treatment to reduce substance use in young adults.

Rita Redberg, MD, MS

Professor
Medicine

Dr. Rita Redberg is a cardiologist, and directs women’s cardiovascular services and the UCSF Flight Attendant Clinic. Her research interests are in the effects of secondhand smoke and other work related conditions (radiation) on flight attendants, as well as in technology assessment and preventive cardiology. Rita Redberg is a Professor of Medicine in the Division of Cardiology at the UCSF School of Medicine and is also Director of Women’s Cardiovascular Services. She is the Editor of the Archives of Internal Medicine.

Mark Rubinstein, MD

Professor
Pediatrics

My research program centers on the development of nicotine dependence in adolescents and young adults. My primary research interest is investigating factors which mediate nicotine addiction in adolescence.  If we can understand the pathways to addiction, it may be possible to find ways to prevent nicotine addiction before it occurs. My current projects focus on electronic cigarette (e-cig) use and the co-use of tobacco and cannabis in adolescents.

Sujatha Sankaran, MD

Associate Clinical Professor
Medicine

Sujatha Sankaran is an Associate Professor of Medicine with the Division of Hospital Medicine. She received her medical degree from the University of Southern California Keck School of Medicine and subsequently completed her training in Internal Medicine at the Georgetown Universty/Washington Hospital Center program in June 2005. She then worked as an Academic Hospitalist at Columbia University in New York City, where she was actively involved in resident education. Subsequently, Sujatha volunteered in sub Saharan Africa.

Jason Satterfield, PhD

Dir of Behavioral Medicine
Medicine

Suzaynn Schick, PhD

Assistant Adjunct Professor
Medicine

I study the health effects of air pollution in human subjects. I focus on the chemistry and toxicity of smoke and on how smoking and using electronic cigarettes can cause heart and lung disease. My analysis of tobacco industry research showed that sidestream cigarette smoke (the primary constituent of secondhand cigarette smoke) is more toxic than the smoke that smokers inhale and that secondhand smoke becomes more toxic as it ages.

Steve Schroeder, MD

Distinguished Professor of Health and Health Care
Medicine

Dr. Schroeder is Distinguished Professor of Health and Health Care, Division of General Internal Medicine, Department of Medicine, UCSF, where he also heads the Smoking Cessation Leadership Center. The Center, funded by the Robert Wood Johnson Foundation and the Truth Initiative, works with leaders of more than 80 American health professional organizations and health care institutions to increase the cessation rate for smokers.

Joel Simon, MD, MPH

Professor Emeritus
Medicine

Research has centered on hospital-based and out-patient clinical trials of smoking cessation. Completed studies include: Transdermal Nicotine Therapy for Hospitalized Smokers and Bupropion for Hospital-Based Smoking Cessation.    Dr.

Elizabeth Smith, PhD

Associate Adjunct Professor
Social Behavioral Sciences

Dr. Smith's work focuses on tobacco control policy and the tobacco industry. Past projects include work on the tobacco industry's influence on and relationships with the lesbian, gay, bisexual and transgender communities, tobacco industry interest in diet and obesity issues, and tobacco product waste and pollution. Her current work explores tobacco control policy issues in the U.S.

Joanne Spetz, PhD

PROF IN RES-HCOMP
Institute for Health Policy Studies

Joanne Spetz, Ph.D., is a Professor at the Institute for Health Policy Studies, Department of Family and Community Medicine, and School of Nursing at the University of California, San Francisco. She is the Associate Director for Research at the Healthforce Center at UCSF and the Director of the UCSF Health Workforce Research Center for Long-Term Care.

Matthew Springer, PhD

Professor of Medicine
Medicine

RESEARCH INTERESTS:

Dr. Matthew L. Springer received his BA from the University of California, Berkeley in 1985 and his PhD from Stanford University in 1992. He did postdoctoral research at Stanford and continued his research there as a senior scientist until joining the UCSF faculty in 2003, where he is currently one of two non-clinicians on the faculty of the Division of Cardiology. The close juxtaposition of his basic research background with the clinical cardiologists in the Division has resulted in an active translational research program.

Gideon St Helen, PhD

Asst. Professor In Residence
Medicine

The focus of my research program in the Division of Clinical Pharmacology, as shown in the image below, is the utility and evaluation of biological markers (biomarkers) of tobacco use and exposure for epidemiology, risk assessment, product regulation, and identification of susceptibility factors.

Research Themes Visual- information below

Hugh Sturrock, PhD

Assistant Professor
Epidemiology & Biostatistics

Hai-Yen Sung, PhD

Adjunct Professor, Institute for Health & Aging
Institute for Health Aging

Research focuses on costs of smoking, costs of illness, evaluation of the economic impact of tobacco taxation and other tobacco control policies, secondhand smoke exposure, and cancer screening and outcomes. Dr.

Janice Tsoh, PhD

Professor In Residence
Psychiatry

I am a practicing clinical psychologist and Professor of Psychiatry at the University of California San Francisco (UCSF). The mission of my research program is to promote health equity by developing accessible interventions to facilitate individuals' acquisition of skills and/or utilization of evidence-based treatment.

Yvette Van Der Eijk, PhD

Postdoc Scholar
Cardiovascular Research Inst

Yvette did a PhD in public health ethics at the Centre for Biomedical Ethics, National University of Singapore and a BSc in Biochemistry (Pharmacology) at the University of Surrey, UK. As part of her studies, she was also based at the University of Turku (Finland), Hastings Center (New York), University of Tübingen (Germany), Brocher Foundation (Switzerland), and WHO Regional Office for Europe (Denmark). After her PhD she worked as a Public Health Analyst at Newcastle City Council, UK, and as a freelance consultant for the WHO Regional Office for Europe's tobacco control programme.

Maya Vijayaraghavan, MD, MAS

Assistant Professor of Med
Medicine

My research focuses on tobacco use in vulnerable populations, with a particular emphasis on interventions with the homeless population. My population-based research includes the analysis of cross-sectional and longitudinal data, including the analysis of national data, to examine the use of novel tobacco products and the efficacy of tobacco control policies on reducing tobacco use in low-income populations.

Manali Vora, BDS

Postdoc Scholar
Cardiovascular Research Inst

Manali Vora, DDS earned her DDS in Dental Surgery from Gujarat University, India in 2014, recently received her MPH in Epidemiology at University of Washington, Seattle. She was sensitized to the tobacco epidemic during her training as a dentist and has since then been passionate about tobacco dependence prevention and treatment research.

Priyanka Vyas, PhD

Postdoc Scholar
Cardiovascular Research Inst

Priyanka Vyas, PhD started her career as a journalist in New Delhi, after completing her BA in political science from Wilson College, Mumbai.  During her stint as a reporter covering trade and policy issues, she became interested in how policies could be better analyzed and implemented.  This single most desire to influence policy decisions led her to move to the US for further education.

Yingning Wang, PhD

ASST ADJ PROF-HCOMP
Institute for Health Aging

Dr. Wang's current research areas include: nondaily smokers, other tobacco use, the correlation between quitting, cigarette consumption reduction and other tobacco use, economic cost of tobacco products use and secondhand smoke exposure.

Shannon Watkins, PhD

Postdoc Scholar
Cardiovascular Research Inst

Shannon Lea Watkins received a PhD in Public Affairs from the School of Public and Environmental Affairs at Indiana University (2015) and a BPhil in Political Science and History from the University of Pittsburgh (2009). Her dissertation focused on urban forests as a linked human-environment system and examined the environmental, social, and distributional effect of urban non-profit tree-planting programs.

Justin White, PhD

Asst Professor in Residence
Institute for Health Policy Studies

Justin White, Ph.D., is Assistant Professor of Health Economics in the UCSF School of Medicine, with joint appointments in the Philip R. Lee Institute for Health Policy Studies and the Department of Epidemiology and Biostatistics. He is also an affiliate of the Center for Tobacco Control Research and Education and Global Health Sciences at UCSF.

Prescott Woodruff, MD, MPH

Assistant Professor of Medicine in Residence
Medicine

esearch program includes clinical and basic science approaches to study the effects of cigarette smoke on lung inflammation. He is also the Principal Investigator on the NIH-funded Spiromics Project and a Co-investigator on the COPD Clinical Research Network. Dr. Woodruff received his B.A, from Wesleyan University in 1989, received his M.D. degree from the Columbia College of Physicians and Surgeons in 1993, and completed Internal Medicine residency training at the Massachusetts General Hospital.

Tingting Yao, PhD

ASST ADJ PROF-HCOMP
Institute for Health Aging

Dr. Yao's research focuses on the economic impact of tobacco products. Her current studies include estimating the economic costs of secondhand smoke (SHS) exposure and the impact of price on the demand for electronic cigarettes in U.S. Her previous research include estimating healthcare costs of SHS exposure and analyzing cigarette purchasing behaviors among smokers in China.

Valerie Yerger, MA, ND

Associate Professor
Social Behavioral Sciences

Dr. Yerger's research focuses on the tobacco industry’s targeting of African American communities, the use of menthol in tobacco products, smoke-free policies in multi-unit housing. Dr. Valerie Yerger is a licensed naturopathic doctor and Associate Professor in Health Policy at the University of California, San Francisco. She received her doctorate in naturopathic medicine from Bastyr University, who honored her as one of its Distinguished Alumni when the award was first presented in 2004.

Dorie Apollonio, PhD

Associate Professor
Clinical Pharmacy

Dr. Dorie Apollonio is an Associate Professor of health policy in the Department of Clinical Pharmacy at the University of California, San Francisco focusing on tobacco control and policy making. Her research considers the role of scientific evidence and interest group lobbying in decision making on public health. This work uses multiple data sources including internal industry documents, campaign finance reports, administrative datasets, and interviews, and relies on both qualitative and quantitative methods to identify how policy affecting public health is made.